Abstract

As with castles, tumor cells are fortified by surrounding non-malignant cells, such as cancer-associated fibroblasts, immune cells, but also nerve fibers and extracellular matrix. In most cancers, this fortification creates a considerable solid pressure which limits oxygen and nutrient delivery to the tumor cells and causes a hypoxic and nutritional stress. Consequently, tumor cells have to adapt their metabolism to survive and proliferate in this harsh microenvironment. To satisfy their need in energy and biomass, tumor cells develop new capacities to benefit from metabolites of the microenvironment, either by their uptake through the macropinocytosis process or through metabolite transporters, or by a cross-talk with stromal cells and capture of extracellular vesicles that are released by the neighboring cells. However, the microenvironments of primary tumor and metastatic niches differ tremendously in their cellular/acellular components and available nutrients. Therefore, cancer cells must develop a metabolic flexibility conferring on them the ability to satisfy their biomass and energetic demands at both primary and metastasis sites. In this review, we propose a brief overview of how proliferating cancer cells take advantage of their surrounding microenvironment to satisfy their high metabolic demand at both primary and metastasis sites.

Highlights

  • Cellular heterogeneity of solid tumors strongly impacts tumor progression

  • Even if pancreatic-cancer-associated fibroblasts (CAFs) are prone to glycolysis [9], the lactate is secreted at a lower rate than alanine, a non-essential amino acid (NEAA) [10]

  • Metabolic cooperation between the tumor microenvironment (TME) and cancer cells contributes to tumor growth, especially in nutrient- or oxygen-deprived microenvironments

Read more

Summary

Introduction

Cellular heterogeneity of solid tumors strongly impacts tumor progression. This abundant heterocellularity drives the nature and abundance of the components of the extracellular matrix (ECM) and, for some cancers, makes tumor cells the minor cell type in terms of cellular amount. We highlight how the stroma [mainly cancer-associated fibroblasts (CAFs)]-tumor cell metabolic axis increases the metabolic performance of tumor cells in addition to the cell’s autonomous metabolic pathways. Cancer-associated metabolic remodeling is not restricted to malignant cells but is found in tumor-surrounding, nontransformed stromal cells.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.